Index RUT
P/E -
EPS (ttm) -1.67
Insider Own 12.31%
Shs Outstand 50.05M
Perf Week 0.11%
Market Cap 460.97M
Forward P/E 26.40
EPS next Y 0.35
Insider Trans 0.35%
Shs Float 43.98M
Perf Month -9.72%
Income -83.00M
PEG -
EPS next Q 0.05
Inst Own 97.12%
Short Float 6.04%
Perf Quarter 4.31%
Sales 1.04B
P/S 0.44
EPS this Y 22.48%
Inst Trans -
Short Ratio 4.05
Perf Half Y -12.23%
Book/sh 13.39
P/B 0.69
EPS next Y 29.18%
ROA -5.59%
Short Interest 2.66M
Perf Year -14.59%
Cash/sh 0.79
P/C 11.70
EPS next 5Y -
ROE -11.72%
52W Range 7.12 - 14.59
Perf YTD -11.21%
Dividend Est. -
P/FCF 16.35
EPS past 5Y -
ROI -6.67%
52W High -37.01%
Beta 1.42
Dividend TTM -
Quick Ratio 1.50
Sales past 5Y -1.04%
Gross Margin 45.56%
52W Low 29.07%
ATR (14) 0.44
Dividend Ex-Date -
Current Ratio 1.50
EPS Y/Y TTM -311.84%
Oper. Margin 3.54%
RSI (14) 47.65
Volatility 3.21% 5.15%
Employees 10800
Debt/Eq 0.90
Sales Y/Y TTM -2.82%
Profit Margin -7.95%
Recom 3.12
Target Price 9.32
Option/Short Yes / Yes
LT Debt/Eq 0.85
EPS Q/Q -92.58%
Payout -
Rel Volume 0.72
Prev Close 9.20
Sales Surprise -2.25%
EPS Surprise 50.86%
Sales Q/Q -1.02%
Earnings May 08 AMC
Avg Volume 655.89K
Price 9.19
SMA20 0.88%
SMA50 -8.70%
SMA200 -9.59%
Trades
Volume 474,196
Change -0.11%
Date
Action
Analyst
Rating Change
Price Target Change
May-14-24 Upgrade
Leerink Partners
Underperform → Market Perform
$8.50
May-09-24 Downgrade
Jefferies
Buy → Hold
$14 → $8.75
Mar-07-24 Upgrade
UBS
Sell → Neutral
$9.50
Dec-12-23 Initiated
TD Cowen
Market Perform
$12
Jun-20-23 Initiated
SVB Securities
Underperform
$10
Mar-16-23 Initiated
Goldman
Neutral
$15
Dec-13-22 Initiated
CJS Securities
Market Perform
$18
Dec-08-22 Initiated
UBS
Sell
$12
Dec-06-22 Initiated
Stifel
Buy
$17
Oct-14-22 Initiated
Oppenheimer
Perform
Aug-30-22 Initiated
Jefferies
Buy
$20
Aug-25-22 Initiated
Credit Suisse
Neutral
$19
Aug-18-22 Initiated
Citigroup
Neutral
$17
Show Previous Ratings
May-29-24 09:00AM
May-23-24 04:30PM
May-21-24 04:10PM
May-20-24 04:10PM
May-14-24 07:54AM
03:01PM
Loading…
May-10-24 03:01PM
11:24AM
May-09-24 01:47PM
Hedge Fund and Insider Trading News: John Paulson, Ken Griffin, Marshall Wace LLP, Bridgewater Associates, AREX Capital Management, Ancora Advisors, Millennium Management, Balyasny Asset Management, Caesars Entertainment Inc (CZR), Vestis Corporation (VSTS), and More
(Insider Monkey) -14.54%
09:15AM
07:13AM
May-08-24 06:55PM
05:48PM
(Associated Press Finance)
04:15PM
04:10PM
Apr-10-24 04:10PM
05:45PM
Loading…
Mar-20-24 05:45PM
Mar-10-24 08:38AM
Mar-07-24 01:39PM
Mar-06-24 09:52PM
04:51PM
(Associated Press Finance)
04:15PM
Feb-08-24 04:10PM
Dec-17-23 05:05AM
Nov-12-23 08:57AM
Nov-09-23 01:24AM
(Thomson Reuters StreetEvents)
Nov-07-23 07:15PM
06:10PM
(Associated Press Finance)
04:11PM
Nov-02-23 10:00AM
Oct-31-23 10:01AM
06:30PM
Loading…
Oct-25-23 06:30PM
Oct-05-23 10:00AM
Oct-04-23 04:41PM
Oct-03-23 05:47PM
Aug-23-23 04:51PM
Aug-14-23 09:00AM
Aug-12-23 09:27AM
Aug-11-23 12:12AM
(Thomson Reuters StreetEvents)
Aug-09-23 06:40PM
05:36PM
04:30PM
Aug-08-23 07:50AM
Jul-27-23 11:00AM
Jul-20-23 08:33AM
Jun-21-23 08:00PM
Jun-13-23 09:00AM
Jun-01-23 04:10PM
May-10-23 11:58PM
(Thomson Reuters StreetEvents) -8.73%
May-09-23 06:34PM
04:10PM
Apr-26-23 08:00PM
11:35AM
Apr-20-23 07:00AM
Apr-19-23 08:58AM
Apr-13-23 08:00AM
Apr-04-23 01:19PM
Mar-30-23 08:46AM
Mar-27-23 08:56AM
Mar-02-23 07:51AM
Feb-23-23 07:00AM
Feb-16-23 06:29PM
Feb-14-23 07:03PM
Jan-24-23 07:00AM
Jan-19-23 11:06AM
Jan-11-23 05:15AM
Dec-27-22 10:00AM
Dec-12-22 04:20PM
Dec-07-22 08:05AM
Dec-01-22 09:07PM
Nov-29-22 10:00AM
Nov-26-22 08:04PM
Nov-14-22 02:00PM
Nov-10-22 06:47AM
Nov-08-22 05:25AM
Nov-03-22 02:00PM
Nov-01-22 05:40PM
Oct-27-22 07:23AM
Oct-05-22 08:30AM
Oct-03-22 04:20PM
Sep-23-22 07:45AM
Aug-23-22 08:30AM
Aug-01-22 04:20PM
Jul-07-22 08:00AM
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bolton Jeffrey Director May 17 '24 Buy 8.33 10,000 83,300 52,299 May 17 05:57 PM Hoeflinger Erin Director May 14 '24 Buy 9.00 2,000 18,000 30,399 May 15 06:29 PM Bolton Jeffrey Director May 10 '24 Buy 8.24 10,000 82,400 42,299 May 10 05:27 PM Langham Ronald Leroy JR EVP Clinical Excel. & Strategy Mar 01 '24 Sale 8.81 634 5,586 57,164 Mar 05 05:48 PM
Index RUT
P/E 28.52
EPS (ttm) 4.03
Insider Own 2.08%
Shs Outstand 16.23M
Perf Week 5.29%
Market Cap 1.88B
Forward P/E 21.42
EPS next Y 5.36
Insider Trans -6.98%
Shs Float 16.03M
Perf Month 16.68%
Income 65.67M
PEG 1.90
EPS next Q 1.21
Inst Own 95.85%
Short Float 1.93%
Perf Quarter 22.32%
Sales 1.09B
P/S 1.73
EPS this Y 7.67%
Inst Trans 2.48%
Short Ratio 2.47
Perf Half Y 30.91%
Book/sh 44.30
P/B 2.59
EPS next Y 8.68%
ROA 6.75%
Short Interest 0.31M
Perf Year 27.35%
Cash/sh 4.69
P/C 24.50
EPS next 5Y 15.00%
ROE 9.56%
52W Range 78.35 - 112.91
Perf YTD 23.65%
Dividend Est. -
P/FCF 15.39
EPS past 5Y 23.63%
ROI 7.60%
52W High 1.68%
Beta 1.01
Dividend TTM -
Quick Ratio 1.35
Sales past 5Y 15.56%
Gross Margin 31.09%
52W Low 46.53%
ATR (14) 2.61
Dividend Ex-Date -
Current Ratio 1.35
EPS Y/Y TTM 29.73%
Oper. Margin 9.36%
RSI (14) 72.60
Volatility 2.01% 2.49%
Employees 34846
Debt/Eq 0.21
Sales Y/Y TTM 11.45%
Profit Margin 6.04%
Recom 1.56
Target Price 118.62
Option/Short Yes / Yes
LT Debt/Eq 0.19
EPS Q/Q 24.30%
Payout 0.00%
Rel Volume 1.15
Prev Close 111.73
Sales Surprise 0.45%
EPS Surprise 8.88%
Sales Q/Q 11.58%
Earnings May 06 AMC
Avg Volume 125.64K
Price 114.81
SMA20 6.28%
SMA50 11.94%
SMA200 24.40%
Trades
Volume 144,559
Change 2.76%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Downgrade
Barclays
Equal Weight → Underweight
$83
Mar-06-24 Initiated
Barclays
Equal Weight
$88
Feb-05-24 Resumed
William Blair
Outperform
Dec-12-23 Initiated
TD Cowen
Outperform
$105
Jun-29-22 Initiated
Stifel
Buy
$101
Apr-13-22 Initiated
BofA Securities
Buy
$110
Oct-22-19 Resumed
Stephens
Overweight
Jun-27-19 Initiated
BMO Capital Markets
Market Perform
Feb-04-19 Upgrade
Robert W. Baird
Neutral → Outperform
Oct-08-18 Initiated
RBC Capital Mkts
Outperform
$81
Aug-21-18 Initiated
Jefferies
Buy
$75
Aug-20-18 Initiated
Raymond James
Outperform
$75
Sep-30-14 Upgrade
Oppenheimer
Perform → Outperform
$24
Jul-16-13 Downgrade
Robert W. Baird
Outperform → Neutral
$14 → $20
Apr-04-13 Downgrade
Oppenheimer
Outperform → Perform
$12 → $13
Dec-07-09 Initiated
Robert W. Baird
Outperform
$13
Dec-07-09 Initiated
Oppenheimer
Outperform
$12
Show Previous Ratings
May-29-24 11:00AM
09:00AM
May-21-24 08:00AM
May-09-24 09:15AM
May-08-24 04:04PM
03:24AM
Loading…
03:24AM
May-07-24 11:00AM
09:19AM
06:11AM
May-06-24 06:33PM
06:30PM
06:05PM
05:03PM
(Associated Press Finance)
04:05PM
May-02-24 09:40AM
09:18AM
Loading…
Apr-23-24 09:18AM
08:00AM
Apr-22-24 11:00AM
Apr-13-24 12:18PM
Apr-09-24 09:00AM
Mar-05-24 11:00AM
Mar-04-24 09:15AM
Mar-01-24 08:30AM
Feb-29-24 12:00PM
Feb-27-24 11:00AM
Feb-26-24 06:30PM
04:54PM
(Associated Press Finance)
04:53PM
04:05PM
Feb-21-24 09:15AM
11:00AM
Loading…
Feb-12-24 11:00AM
Nov-22-23 09:55AM
Nov-17-23 05:05AM
Nov-06-23 09:55AM
Nov-01-23 12:37PM
11:00AM
Oct-30-23 05:50PM
05:43PM
04:50PM
(Associated Press Finance)
04:05PM
Oct-23-23 10:15AM
Oct-19-23 11:40AM
Oct-17-23 06:21AM
Oct-16-23 12:00PM
08:58AM
Oct-10-23 09:40AM
Oct-03-23 11:40AM
Sep-25-23 03:21AM
Sep-24-23 10:30AM
Aug-02-23 04:05PM
Aug-01-23 08:00AM
Jul-31-23 06:25PM
05:12PM
04:05PM
Jul-29-23 11:30AM
Jul-24-23 10:00AM
Jul-23-23 09:03AM
Jul-20-23 12:10PM
Jul-17-23 01:00PM
Jul-03-23 01:01PM
Jun-29-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-09-23 01:39PM
Jun-08-23 12:44PM
Jun-07-23 01:53PM
12:52PM
Jun-06-23 10:20AM
Jun-05-23 02:12PM
11:45AM
11:40AM
Jun-02-23 12:44PM
Jun-01-23 11:28AM
11:17AM
10:14AM
May-31-23 12:04PM
May-29-23 09:55AM
May-26-23 10:55AM
May-25-23 02:30PM
09:35AM
May-24-23 01:42PM
11:00AM
May-23-23 11:23AM
11:01AM
May-22-23 11:13AM
10:48AM
May-19-23 11:39AM
10:48AM
May-18-23 01:12PM
01:09PM
11:40AM
10:50AM
May-17-23 02:15PM
May-11-23 09:40AM
May-09-23 11:00AM
09:35AM
May-02-23 11:16PM
(Thomson Reuters StreetEvents)
11:00AM
May-01-23 05:45PM
04:05PM
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Stevenson Roberton James EVP & Chief HR Officer Apr 01 '24 Sale 103.93 109 11,328 10,434 Apr 02 04:05 PM RAINES MONICA EVP/CCO and Quality Officer Mar 04 '24 Sale 93.86 235 22,057 11,986 Mar 05 04:09 PM ALLISON R DIRK CEO and Chairman Feb 26 '24 Sale 85.95 8,021 689,405 79,397 Feb 27 04:10 PM BICKHAM W BRADLEY President and COO Feb 26 '24 Sale 85.95 5,212 447,971 48,000 Feb 27 04:10 PM POFF BRIAN EVP/Chief Financial Officer Feb 26 '24 Sale 85.95 4,814 413,763 31,544 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Feb 26 '24 Sale 85.94 1,763 151,512 40,754 Feb 27 04:10 PM GAFFNEY SEAN EVP/Chief Legal Officer Feb 26 '24 Sale 85.95 1,639 140,872 18,002 Feb 27 04:10 PM TUCKER DAVID W. EVP/Chief Strategy Officer Feb 26 '24 Sale 85.96 1,347 115,788 10,497 Feb 27 04:10 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Feb 26 '24 Sale 85.95 1,176 101,077 9,132 Feb 27 04:10 PM Stevenson Roberton James EVP & Chief HR Officer Feb 26 '24 Sale 85.95 714 61,368 10,543 Feb 27 04:10 PM RAINES MONICA EVP/CCO and Quality Officer Feb 26 '24 Sale 85.96 538 46,246 12,221 Feb 27 04:10 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Option Exercise 23.10 9,690 223,839 46,550 Nov 16 04:39 PM Anderson Darby EVP/Chief Legislative Officer Nov 14 '23 Sale 85.00 9,690 823,650 36,860 Nov 16 04:39 PM TUCKER DAVID W. EVP / Chief Strategy Officer Nov 08 '23 Sale 83.45 248 20,696 6,973 Nov 09 05:13 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Nov 08 '23 Sale 83.45 235 19,611 5,987 Nov 09 05:14 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Option Exercise 23.10 3,008 69,485 39,868 Nov 09 05:13 PM Anderson Darby EVP/Chief Legislative Officer Nov 07 '23 Sale 85.00 3,008 255,680 36,860 Nov 09 05:13 PM BICKHAM W BRADLEY President and COO Aug 07 '23 Sale 93.85 5,000 469,250 38,285 Aug 08 05:01 PM TUCKER DAVID W. EVP / Chief Strategy Officer Aug 07 '23 Sale 94.23 1,636 154,160 7,221 Aug 08 05:01 PM WATTENBARGER MICHAEL D. EVP/Chief Information Officer Aug 07 '23 Sale 93.96 750 70,470 6,222 Aug 08 05:02 PM POFF BRIAN EVP/Chief Financial Officer Aug 04 '23 Sale 93.55 4,140 387,316 22,217 Aug 04 05:30 PM ALLISON R DIRK CEO and Chairman Aug 03 '23 Sale 94.39 24,922 2,352,473 52,850 Aug 04 05:29 PM Stevenson Roberton James EVP & Chief HR Officer Jun 15 '23 Sale 92.61 217 20,096 7,329 Jun 20 05:02 PM
Index -
P/E 29.85
EPS (ttm) 18.57
Insider Own 2.19%
Shs Outstand 15.03M
Perf Week -0.17%
Market Cap 8.39B
Forward P/E 21.93
EPS next Y 25.28
Insider Trans -6.04%
Shs Float 14.81M
Perf Month -2.07%
Income 283.40M
PEG 2.65
EPS next Q 5.59
Inst Own 96.42%
Short Float 2.05%
Perf Quarter -9.68%
Sales 2.29B
P/S 3.66
EPS this Y 14.33%
Inst Trans 1.15%
Short Ratio 3.88
Perf Half Y -2.22%
Book/sh 78.46
P/B 7.07
EPS next Y 8.90%
ROA 17.94%
Short Interest 0.30M
Perf Year 3.86%
Cash/sh 20.70
P/C 26.79
EPS next 5Y 11.25%
ROE 27.47%
52W Range 492.84 - 654.62
Perf YTD -5.20%
Dividend Est. 1.64 (0.30%)
P/FCF 27.76
EPS past 5Y 7.95%
ROI 21.96%
52W High -15.31%
Beta 0.46
Dividend TTM 1.60 (0.29%)
Quick Ratio 1.88
Sales past 5Y 4.95%
Gross Margin 32.77%
52W Low 12.48%
ATR (14) 8.91
Dividend Ex-Date May 30, 2024
Current Ratio 1.91
EPS Y/Y TTM 17.00%
Oper. Margin 14.83%
RSI (14) 38.76
Volatility 1.65% 1.40%
Employees 15087
Debt/Eq 0.13
Sales Y/Y TTM 5.96%
Profit Margin 12.36%
Recom 1.25
Target Price 686.12
Option/Short Yes / Yes
LT Debt/Eq 0.09
EPS Q/Q 18.34%
Payout 8.70%
Rel Volume 1.33
Prev Close 548.16
Sales Surprise -0.38%
EPS Surprise -5.11%
Sales Q/Q 5.19%
Earnings Apr 24 AMC
Avg Volume 78.24K
Price 554.37
SMA20 -1.53%
SMA50 -6.80%
SMA200 -3.02%
Trades
Volume 104,433
Change 1.13%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-20 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$448 → $535
Nov-01-19 Upgrade
JMP Securities
Mkt Perform → Mkt Outperform
$490
Sep-06-19 Reiterated
BofA/Merrill
Buy
$470 → $500
Oct-12-18 Initiated
BofA/Merrill
Buy
$390
Aug-28-17 Initiated
KeyBanc Capital Mkts
Sector Weight
Nov-01-16 Reiterated
RBC Capital Mkts
Sector Perform
$162 → $148
Jul-27-16 Reiterated
RBC Capital Mkts
Sector Perform
$136 → $162
May-02-16 Reiterated
RBC Capital Mkts
Sector Perform
$135 → $136
Oct-26-15 Reiterated
RBC Capital Mkts
Sector Perform
$129 → $154
Oct-26-15 Reiterated
Oppenheimer
Outperform
$150 → $152
Sep-22-15 Reiterated
Oppenheimer
Outperform
$147 → $150
Jul-27-15 Reiterated
RBC Capital Mkts
Sector Perform
$110 → $129
Feb-19-15 Reiterated
Oppenheimer
Outperform
$122 → $123
Sep-23-14 Reiterated
Oppenheimer
Outperform
$110 → $115
Jun-10-14 Reiterated
RBC Capital Mkts
Sector Perform
$70 → $74
May-01-14 Reiterated
Oppenheimer
Outperform
$90 → $92
Sep-10-13 Reiterated
Deutsche Bank
Hold
$70 → $63
Mar-04-11 Reiterated
Barclays Capital
Underweight
$65 → $9
Feb-17-11 Reiterated
RBC Capital Mkts
Sector Perform
$53 → $67
Feb-17-11 Reiterated
Oppenheimer
Outperform
$67 → $72
Show Previous Ratings
May-29-24 12:00PM
May-24-24 11:31AM
May-20-24 02:49PM
May-17-24 03:00PM
11:15AM
12:00PM
Loading…
May-07-24 12:00PM
Apr-30-24 12:15PM
Apr-26-24 12:35PM
03:17AM
Apr-25-24 11:37PM
(Thomson Reuters StreetEvents) -7.22%
08:27AM
Apr-24-24 06:10PM
05:35PM
05:14PM
05:05PM
(Associated Press Finance)
04:15PM
Loading…
04:15PM
Apr-17-24 10:26AM
10:00AM
Apr-03-24 04:29AM
Apr-01-24 03:00PM
12:00PM
Mar-28-24 11:30AM
Mar-22-24 03:00PM
Mar-18-24 09:45AM
Mar-14-24 09:00AM
Mar-13-24 09:00AM
Mar-08-24 12:00PM
Mar-04-24 12:45PM
Feb-29-24 09:03AM
06:37AM
12:15AM
Loading…
12:15AM
(Thomson Reuters StreetEvents)
Feb-27-24 08:00PM
07:15PM
06:20PM
(Associated Press Finance)
04:53PM
04:15PM
Feb-16-24 12:27PM
Feb-14-24 12:00PM
Feb-05-24 10:59AM
Jan-22-24 08:29AM
Jan-08-24 11:24AM
Dec-29-23 12:00PM
Dec-25-23 07:14AM
Dec-22-23 04:18PM
Dec-18-23 01:20PM
Dec-14-23 09:05PM
Nov-30-23 03:00PM
Nov-28-23 05:04AM
Nov-24-23 11:31AM
Nov-17-23 09:55AM
Nov-15-23 10:10PM
Nov-13-23 07:33PM
Nov-08-23 10:33AM
Nov-06-23 09:00AM
Nov-03-23 04:15PM
11:28AM
05:03AM
Nov-02-23 01:03AM
Oct-27-23 03:04PM
08:08AM
12:31AM
(Thomson Reuters StreetEvents)
Oct-25-23 09:30PM
06:50PM
06:26PM
05:47PM
(Associated Press Finance)
04:15PM
Oct-20-23 11:40AM
Oct-11-23 12:00PM
Oct-04-23 11:40AM
Sep-25-23 07:25AM
Sep-18-23 11:40AM
Sep-14-23 10:48AM
Aug-31-23 11:40AM
Aug-15-23 01:20PM
Aug-08-23 06:28AM
Aug-07-23 07:08AM
Aug-04-23 11:56AM
Jul-27-23 08:23AM
Jul-26-23 10:00PM
06:45PM
05:43PM
04:15PM
Jul-21-23 09:56AM
Jul-20-23 11:40AM
Jul-12-23 12:00PM
Jul-10-23 08:25AM
Jun-21-23 08:00PM
Jun-14-23 09:53AM
Jun-06-23 08:40AM
Jun-05-23 08:56AM
Jun-01-23 12:00PM
May-24-23 09:03AM
May-15-23 02:43PM
May-10-23 12:00PM
11:40AM
May-09-23 06:40AM
May-03-23 12:00PM
May-02-23 03:14PM
06:39AM
Apr-30-23 09:13AM
Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCNAMARA KEVIN J president and CEO May 16 '24 Sale 567.54 4,000 2,270,160 108,549 May 17 11:05 AM Witzeman Michael D VP & Chief Financial Officer May 07 '24 Option Exercise 413.19 1,100 454,509 3,982 May 09 01:34 PM LEE SPENCER S executive vice president Mar 28 '24 Option Exercise 106.59 13,000 1,385,670 33,760 Apr 01 11:43 AM LEE SPENCER S executive vice president Mar 28 '24 Sale 641.65 2,000 1,283,300 20,760 Apr 01 11:43 AM Witzeman Michael D VP & Chief Financial Officer Mar 21 '24 Sale 643.14 2,650 1,704,321 2,882 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Option Exercise 443.22 11,958 5,300,013 12,580 Mar 22 11:26 AM Witzeman Michael D VP & Chief Financial Officer Mar 20 '24 Option Exercise 413.19 2,600 1,074,294 5,887 Mar 22 01:21 PM Judkins Brian C VP and Chief Legal Officer Mar 20 '24 Sale 645.00 11,158 7,196,910 1,422 Mar 22 11:26 AM HUTTON THOMAS C vice president Mar 06 '24 Option Exercise 449.03 3,267 1,466,992 39,592 Mar 07 12:59 PM MCNAMARA KEVIN J president and CEO Feb 16 '24 Option Exercise 586.49 2,704 1,585,869 114,172 Feb 20 11:28 AM Westfall Nicholas Michael Executive Vice President Feb 16 '24 Option Exercise 586.49 785 460,395 8,461 Feb 20 03:12 PM LEE SPENCER S executive vice president Feb 16 '24 Option Exercise 586.49 480 281,515 23,048 Feb 20 03:15 PM Witzeman Michael D VP & Chief Financial Officer Feb 16 '24 Option Exercise 586.49 433 253,950 3,417 Feb 20 03:09 PM Judkins Brian C VP and Chief Legal Officer Feb 16 '24 Option Exercise 586.49 368 215,828 843 Feb 20 03:22 PM HUTTON THOMAS C vice president Feb 16 '24 Option Exercise 586.49 210 123,163 36,402 Feb 20 03:49 PM MCNAMARA KEVIN J president and CEO Dec 11 '23 Sale 572.77 1,500 859,155 111,468 Dec 13 11:56 AM LEE SPENCER S executive vice president Nov 27 '23 Sale 579.73 1,000 579,730 22,568 Nov 27 12:33 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 14 '23 Sale 586.08 1,186 695,091 5,826 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 13 '23 Sale 586.32 3,814 2,236,224 7,012 Nov 15 11:27 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 10 '23 Sale 580.79 5,000 2,903,950 10,826 Nov 13 12:25 PM Witzeman Michael D vice president and controller Nov 08 '23 Option Exercise 413.19 3,300 1,363,527 5,669 Nov 08 02:43 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 07 '23 Sale 583.85 6,000 3,503,100 15,826 Nov 08 11:26 AM LEE SPENCER S executive vice president Nov 07 '23 Sale 583.85 1,217 710,545 23,633 Nov 08 11:29 AM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 03 '23 Option Exercise 460.80 35,235 16,236,196 52,967 Nov 06 01:28 PM WILLIAMS DAVID PATRICK executive vice president & CFO Nov 01 '23 Sale 568.87 5,000 2,844,350 17,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Option Exercise 433.67 15,700 6,808,683 131,615 Nov 01 03:37 PM WILLIAMS DAVID PATRICK executive vice president & CFO Oct 31 '23 Option Exercise 413.19 15,100 6,239,169 22,732 Nov 02 03:45 PM MCNAMARA KEVIN J president and CEO Oct 31 '23 Sale 560.68 5,000 2,803,400 112,968 Nov 01 03:37 PM MCNAMARA KEVIN J president and CEO Aug 04 '23 Option Exercise 413.19 3,000 1,239,570 118,571 Aug 07 10:28 AM MCNAMARA KEVIN J president and CEO Aug 03 '23 Sale 516.43 4,000 2,065,720 115,571 Aug 07 10:28 AM
Index RUT
P/E -
EPS (ttm) -
Insider Own 69.18%
Shs Outstand 171.19M
Perf Week -1.57%
Market Cap 1.93B
Forward P/E 15.18
EPS next Y 0.74
Insider Trans 0.09%
Shs Float 52.80M
Perf Month 5.53%
Income -
PEG -
EPS next Q 0.14
Inst Own 41.23%
Short Float 29.70%
Perf Quarter 25.70%
Sales -
P/S -
EPS this Y 145.75%
Inst Trans -
Short Ratio 10.78
Perf Half Y -
Book/sh 9.16
P/B 1.23
EPS next Y 23.64%
ROA -
Short Interest 15.68M
Perf Year -
Cash/sh 0.34
P/C 33.21
EPS next 5Y -
ROE -
52W Range 7.85 - 12.14
Perf YTD 2.27%
Dividend Est. -
P/FCF -
EPS past 5Y 12.91%
ROI -
52W High -7.33%
Beta -
Dividend TTM -
Quick Ratio 0.96
Sales past 5Y 14.32%
Gross Margin -
52W Low 43.31%
ATR (14) 0.40
Dividend Ex-Date -
Current Ratio 1.26
EPS Y/Y TTM -
Oper. Margin 3.91%
RSI (14) 52.23
Volatility 3.07% 3.62%
Employees 600
Debt/Eq 1.84
Sales Y/Y TTM -
Profit Margin -
Recom 1.00
Target Price 16.05
Option/Short Yes / Yes
LT Debt/Eq 1.75
EPS Q/Q -101.51%
Payout -
Rel Volume 1.27
Prev Close 11.45
Sales Surprise 11.41%
EPS Surprise 220.00%
Sales Q/Q 30.04%
Earnings May 02 BMO
Avg Volume 1.45M
Price 11.25
SMA20 -1.11%
SMA50 4.61%
SMA200 7.66%
Trades
Volume 1,846,797
Change -1.75%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Initiated
HSBC Securities
Buy
$13
Feb-27-24 Upgrade
Deutsche Bank
Hold → Buy
$11.50
Feb-20-24 Initiated
Wells Fargo
Overweight
$15
Feb-20-24 Initiated
UBS
Buy
$15
Feb-20-24 Initiated
Morgan Stanley
Overweight
$18
Feb-20-24 Initiated
Leerink Partners
Outperform
$15
Feb-20-24 Initiated
Jefferies
Buy
$18
Feb-20-24 Initiated
Guggenheim
Buy
$15
Feb-20-24 Initiated
Goldman
Buy
$26
Feb-20-24 Initiated
Deutsche Bank
Hold
$11.50
Feb-20-24 Initiated
BofA Securities
Buy
$14
Show Previous Ratings
May-22-24 04:05PM
07:30AM
May-20-24 07:30AM
May-08-24 09:55AM
May-05-24 08:14AM
03:24AM
Loading…
May-03-24 03:24AM
May-02-24 10:57AM
06:00AM
Apr-26-24 05:09PM
Apr-10-24 04:35PM
Apr-09-24 04:05PM
Apr-04-24 07:30AM
Mar-26-24 07:30AM
Mar-21-24 07:30AM
Mar-20-24 04:35PM
04:45PM
Loading…
Mar-14-24 04:45PM
Mar-01-24 08:42AM
Feb-29-24 06:30AM
Feb-15-24 04:35PM
Jan-26-24 04:50PM
04:20PM
(The Wall Street Journal)
04:05PM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DAmbrosio Matthew Director May 20 '24 Buy 11.46 1,000 11,461 1,000 May 21 06:17 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 369,763 Mar 18 03:26 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 1,025,636 Mar 18 03:26 PM Mattingly James F Jr See Remarks Mar 15 '24 Buy 8.26 6,080 50,221 134,780 Mar 18 03:27 PM Yowler Jennifer President, PharMerica Mar 15 '24 Buy 8.21 3,000 24,630 60,880 Mar 18 03:27 PM ROUSSEAU JON B See Remarks Mar 14 '24 Buy 8.12 37,405 303,729 39,352 Mar 15 05:33 PM Mattingly James F Jr See Remarks Mar 14 '24 Buy 8.18 12,280 100,450 128,700 Mar 15 05:34 PM Phipps Jennifer A Chief Accounting Officer Mar 14 '24 Buy 8.14 12,300 100,122 165,618 Mar 15 05:34 PM
Index RUT
P/E -
EPS (ttm) -5.20
Insider Own 40.39%
Shs Outstand 132.63M
Perf Week -1.46%
Market Cap 1.26B
Forward P/E 8.72
EPS next Y 1.09
Insider Trans -0.65%
Shs Float 79.41M
Perf Month -5.77%
Income -697.92M
PEG -
EPS next Q 0.19
Inst Own 59.08%
Short Float 10.70%
Perf Quarter -9.89%
Sales 3.25B
P/S 0.39
EPS this Y -37.17%
Inst Trans 10.45%
Short Ratio 8.65
Perf Half Y 6.64%
Book/sh 11.31
P/B 0.84
EPS next Y 31.28%
ROA -14.26%
Short Interest 8.50M
Perf Year -9.54%
Cash/sh 0.60
P/C 15.87
EPS next 5Y 14.00%
ROE -38.54%
52W Range 6.37 - 15.37
Perf YTD 30.04%
Dividend Est. -
P/FCF 23.73
EPS past 5Y -
ROI -18.73%
52W High -38.32%
Beta 1.08
Dividend TTM -
Quick Ratio 1.11
Sales past 5Y 62.79%
Gross Margin 13.98%
52W Low 48.82%
ATR (14) 0.48
Dividend Ex-Date -
Current Ratio 1.33
EPS Y/Y TTM -1874.35%
Oper. Margin 8.65%
RSI (14) 42.94
Volatility 5.16% 4.97%
Employees 10700
Debt/Eq 1.60
Sales Y/Y TTM 7.94%
Profit Margin -21.49%
Recom 2.00
Target Price 11.95
Option/Short Yes / Yes
LT Debt/Eq 1.55
EPS Q/Q 70.94%
Payout -
Rel Volume 0.77
Prev Close 9.69
Sales Surprise 2.94%
EPS Surprise 53.37%
Sales Q/Q 6.43%
Earnings May 07 BMO
Avg Volume 981.72K
Price 9.48
SMA20 -3.94%
SMA50 -6.45%
SMA200 5.63%
Trades
Volume 757,390
Change -2.17%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-08-24 Downgrade
Jefferies
Buy → Hold
$14.50 → $8
Nov-08-23 Downgrade
BofA Securities
Neutral → Underperform
$9.50 → $6.50
May-10-23 Downgrade
Stifel
Buy → Hold
$18 → $11
May-10-23 Downgrade
Deutsche Bank
Buy → Hold
$28 → $11.30
May-09-23 Downgrade
BofA Securities
Buy → Neutral
$21 → $12
Sep-27-21 Initiated
SVB Leerink
Outperform
$30
Jul-14-21 Upgrade
Robert W. Baird
Neutral → Outperform
$30 → $36
Apr-13-21 Downgrade
Robert W. Baird
Outperform → Neutral
Mar-18-21 Initiated
Truist
Buy
Jan-26-21 Initiated
BofA Securities
Buy
$46
Dec-10-20 Initiated
UBS
Buy
$49
Aug-10-20 Initiated
Canaccord Genuity
Buy
$31
Jul-01-20 Resumed
SVB Leerink
Outperform
$21
Jun-09-20 Initiated
RBC Capital Mkts
Outperform
$24
Jan-31-20 Initiated
Stifel
Buy
$17
Jan-07-20 Initiated
Jefferies
Buy
$15
Dec-11-19 Initiated
SVB Leerink
Outperform
Dec-10-19 Initiated
Deutsche Bank
Buy
Show Previous Ratings
May-22-24 04:39PM
04:36PM
04:33PM
04:30PM
May-20-24 04:05PM
04:45PM
Loading…
May-14-24 04:45PM
May-08-24 02:57PM
08:00AM
03:19AM
May-07-24 09:48AM
08:43AM
08:36AM
08:10AM
07:00AM
Apr-24-24 09:40AM
08:00AM
Loading…
Apr-18-24 08:00AM
Apr-17-24 06:51PM
04:15PM
Apr-08-24 09:40AM
Mar-22-24 09:40AM
Mar-08-24 11:59AM
Mar-06-24 09:40AM
Mar-04-24 04:05PM
Mar-01-24 08:00AM
Feb-28-24 10:53AM
Feb-27-24 10:53PM
(Thomson Reuters StreetEvents) +31.06%
11:28AM
07:33AM
07:00AM
Feb-08-24 04:05PM
05:05PM
Loading…
Dec-19-23 05:05PM
Nov-10-23 08:00AM
Nov-08-23 05:11PM
Nov-07-23 11:41PM
(Thomson Reuters StreetEvents) -8.99%
08:11AM
07:00AM
Oct-17-23 04:05PM
Oct-11-23 12:07PM
Sep-20-23 12:47PM
(Associated Press Finance) -6.49%
11:44AM
08:54AM
08:45AM
08:38AM
Sep-14-23 07:37PM
01:31PM
Sep-07-23 08:00AM
Aug-17-23 07:17PM
07:31AM
Aug-08-23 10:50AM
06:30AM
Aug-03-23 08:00AM
Aug-02-23 01:24PM
Jul-18-23 08:00AM
Jul-17-23 07:27AM
Jun-28-23 08:12AM
Jun-27-23 08:16AM
Jun-21-23 08:00PM
Jun-20-23 08:40AM
May-19-23 08:32AM
May-15-23 12:28PM
May-11-23 02:00PM
May-09-23 06:18PM
08:55AM
07:35AM
07:35AM
Apr-26-23 08:00PM
Apr-18-23 08:32AM
Apr-17-23 09:10AM
Apr-11-23 04:15PM
Mar-27-23 08:22AM
Mar-02-23 05:44AM
Mar-01-23 05:08AM
01:01AM
(Thomson Reuters StreetEvents)
Feb-28-23 12:00PM
10:55AM
Feb-27-23 07:45PM
05:28PM
Feb-25-23 02:14PM
Feb-21-23 10:00AM
Feb-14-23 07:00AM
Feb-07-23 05:32AM
Jan-11-23 03:13PM
(Investor's Business Daily)
Jan-10-23 07:33PM
11:25AM
Dec-23-22 04:53PM
Dec-21-22 05:15AM
Nov-30-22 12:46PM
10:53AM
Nov-16-22 08:34AM
Nov-10-22 06:23AM
Nov-08-22 12:54PM
08:25AM
07:00AM
Oct-20-22 09:00AM
Oct-18-22 08:08AM
Sep-19-22 08:54AM
Sep-16-22 09:00AM
Sep-13-22 09:55AM
Aug-09-22 02:34PM
02:00PM
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Flynn James E 10% Owner Mar 12 '24 Sale 10.70 114,906 1,229,494 11,528,863 Mar 12 07:01 PM Flynn James E 10% Owner Mar 11 '24 Sale 11.02 182,607 2,012,557 11,643,769 Mar 12 07:01 PM Flynn James E 10% Owner Mar 08 '24 Sale 10.93 52,487 573,652 11,826,376 Mar 12 07:01 PM Williams David Solomon III Director Dec 04 '23 Sale 9.30 2,255 20,972 29,779 Dec 06 05:05 PM SkyKnight Aero Holdings, LLC Director Aug 11 '23 Sale 14.02 137,787 1,931,085 2,815,117 Aug 14 04:23 PM SkyKnight Aero Holdings, LLC Director Aug 11 '23 Sale 14.02 59,052 827,614 5,565,126 Aug 14 04:23 PM Prast Albert A. Chief Technology Officer Aug 10 '23 Option Exercise 2.69 200,000 538,000 310,578 Aug 14 06:59 PM Clemens Jason A Chief Financial Officer Aug 10 '23 Buy 14.10 720 10,152 194,120 Aug 14 06:58 PM Prast Albert A. Chief Technology Officer Aug 10 '23 Sale 14.18 200,000 2,836,179 110,578 Aug 14 06:59 PM SkyKnight Aero Holdings, LLC Director Aug 10 '23 Sale 14.05 90,152 1,266,293 2,952,904 Aug 14 04:23 PM SkyKnight Aero Holdings, LLC Director Aug 10 '23 Sale 14.05 38,636 542,689 5,624,178 Aug 14 04:23 PM
Index RUT
P/E 19.62
EPS (ttm) 1.52
Insider Own 0.87%
Shs Outstand 174.58M
Perf Week 4.27%
Market Cap 5.18B
Forward P/E 21.76
EPS next Y 1.37
Insider Trans 2.23%
Shs Float 172.30M
Perf Month -0.53%
Income 272.67M
PEG 1.96
EPS next Q 0.27
Inst Own 97.56%
Short Float 3.42%
Perf Quarter -7.16%
Sales 4.43B
P/S 1.17
EPS this Y -20.05%
Inst Trans 3.09%
Short Ratio 4.73
Perf Half Y 0.27%
Book/sh 8.22
P/B 3.63
EPS next Y 15.83%
ROA 8.55%
Short Interest 5.89M
Perf Year 8.24%
Cash/sh 1.26
P/C 23.61
EPS next 5Y 10.00%
ROE 19.62%
52W Range 26.17 - 35.74
Perf YTD -11.49%
Dividend Est. -
P/FCF 30.34
EPS past 5Y -
ROI 10.59%
52W High -16.56%
Beta 1.32
Dividend TTM -
Quick Ratio 1.39
Sales past 5Y 17.51%
Gross Margin 21.01%
52W Low 13.95%
ATR (14) 0.71
Dividend Ex-Date -
Current Ratio 1.77
EPS Y/Y TTM 74.47%
Oper. Margin 7.15%
RSI (14) 49.10
Volatility 2.36% 2.07%
Employees 5809
Debt/Eq 0.82
Sales Y/Y TTM 9.59%
Profit Margin 6.15%
Recom 1.11
Target Price 39.33
Option/Short Yes / Yes
LT Debt/Eq 0.80
EPS Q/Q 18.83%
Payout 0.00%
Rel Volume 0.88
Prev Close 29.70
Sales Surprise 4.03%
EPS Surprise 15.15%
Sales Q/Q 12.82%
Earnings Apr 23 BMO
Avg Volume 1.25M
Price 29.82
SMA20 0.36%
SMA50 -2.93%
SMA200 -6.08%
Trades
Volume 1,096,089
Change 0.40%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-27-23 Resumed
Jefferies
Buy
$38
Jul-19-21 Upgrade
Goldman
Neutral → Buy
$20 → $25
Jan-22-21 Initiated
Deutsche Bank
Buy
$22
Jan-11-21 Initiated
JP Morgan
Overweight
$21
Dec-15-20 Initiated
Goldman
Neutral
$18
Jun-24-20 Initiated
BofA/Merrill
Buy
$18
May-16-24 05:23PM
04:05PM
Apr-29-24 04:05PM
Apr-26-24 12:00PM
09:40AM
11:27AM
Loading…
Apr-25-24 11:27AM
Apr-24-24 03:49AM
(Thomson Reuters StreetEvents)
03:03AM
Apr-23-24 11:54AM
08:33AM
08:19AM
08:15AM
07:15AM
(Associated Press Finance)
07:00AM
Apr-22-24 12:10PM
10:00AM
Loading…
Apr-16-24 10:00AM
Apr-04-24 04:05PM
Mar-26-24 05:25PM
Mar-14-24 07:14PM
05:04PM
04:58PM
04:25PM
Mar-07-24 10:07AM
Feb-23-24 12:34PM
Feb-22-24 11:53PM
(Thomson Reuters StreetEvents)
08:20AM
07:31AM
07:24AM
(Associated Press Finance)
07:00AM
Feb-02-24 06:10AM
04:05PM
Loading…
Jan-22-24 04:05PM
Jan-08-24 07:00AM
Dec-19-23 05:14AM
Dec-11-23 04:05PM
Dec-06-23 04:11PM
Nov-07-23 04:05PM
Oct-26-23 09:35AM
Oct-25-23 10:27PM
(Thomson Reuters StreetEvents) -15.49%
07:05PM
09:56AM
08:15AM
07:08AM
(Associated Press Finance)
07:00AM
Oct-20-23 11:47AM
Oct-18-23 12:04PM
Oct-16-23 02:53PM
Oct-02-23 05:56AM
Sep-29-23 03:59PM
08:19AM
Sep-28-23 08:26PM
Sep-27-23 09:24PM
04:05PM
Sep-15-23 09:18AM
Sep-12-23 08:32AM
Sep-08-23 06:23PM
Sep-05-23 07:54AM
Sep-01-23 11:19AM
Aug-31-23 05:00PM
11:40AM
03:34AM
Aug-28-23 09:59AM
Aug-18-23 07:39AM
Aug-14-23 07:03PM
Aug-11-23 09:39AM
Aug-10-23 12:20PM
10:12AM
Aug-03-23 08:06AM
Aug-02-23 07:53AM
07:37AM
Jul-28-23 12:00PM
Jul-27-23 08:25AM
07:20AM
07:00AM
Jul-25-23 05:36AM
Jul-19-23 11:40AM
Jul-06-23 11:22AM
08:00AM
Jun-30-23 01:04PM
Jun-28-23 09:21AM
Jun-27-23 08:18AM
Jun-26-23 01:39PM
(The Wall Street Journal) +5.18%
09:04AM
08:57AM
08:44AM
Jun-21-23 08:00PM
Jun-11-23 03:45AM
Jun-06-23 01:14PM
08:55AM
Jun-05-23 11:40AM
08:31AM
08:25AM
08:13AM
May-23-23 04:05PM
11:53AM
May-18-23 04:05PM
May-05-23 04:05PM
May-04-23 12:29PM
May-03-23 07:35PM
06:27PM
04:53PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Smyser Collin GC & Corporate Secretary May 19 '24 Option Exercise 0.00 812 0 42,120 May 21 04:52 PM Bavaro Michael Chief Human Resources Officer Feb 28 '24 Sale 31.73 1,984 62,944 43,428 Mar 01 04:28 PM KRAEMER HARRY M JANSEN JR Director Feb 26 '24 Buy 31.55 35,000 1,104,352 269,528 Feb 28 04:41 PM RADEMACHER JOHN CHARLES Chief Executive Officer Feb 21 '24 Option Exercise 0.00 11,087 0 705,876 Feb 23 06:21 PM SHAPIRO MICHAEL H. Chief Financial Officer Feb 17 '24 Option Exercise 0.00 3,652 0 180,570 Feb 21 09:55 PM Bierbower Elizabeth D Director Oct 30 '23 Buy 26.37 3,000 79,110 13,515 Nov 01 05:09 PM Pate R Carter Director Aug 17 '23 Buy 34.32 1,465 50,279 106,112 Aug 21 05:08 PM Smyser Collin GC & Corporate Secretary Aug 14 '23 Buy 34.69 2,500 86,725 2,500 Aug 15 05:24 PM KRAEMER HARRY M JANSEN JR Director Aug 11 '23 Buy 34.63 55,000 1,904,518 234,528 Aug 15 05:26 PM
Index RUT
P/E -
EPS (ttm) -0.60
Insider Own 71.67%
Shs Outstand 190.73M
Perf Week -3.69%
Market Cap 502.11M
Forward P/E -
EPS next Y -0.01
Insider Trans 0.00%
Shs Float 54.51M
Perf Month 17.04%
Income -113.70M
PEG -
EPS next Q -0.02
Inst Own 20.37%
Short Float 2.16%
Perf Quarter 9.21%
Sales 1.92B
P/S 0.26
EPS this Y 35.86%
Inst Trans -0.02%
Short Ratio 12.55
Perf Half Y -9.69%
Book/sh -0.71
P/B -
EPS next Y 92.27%
ROA -6.74%
Short Interest 1.18M
Perf Year 121.19%
Cash/sh 0.22
P/C 11.78
EPS next 5Y 6.23%
ROE -567.05%
52W Range 0.85 - 3.07
Perf YTD -2.61%
Dividend Est. -
P/FCF -
EPS past 5Y -22.80%
ROI -9.65%
52W High -14.98%
Beta 2.07
Dividend TTM -
Quick Ratio 0.88
Sales past 5Y 8.64%
Gross Margin 30.43%
52W Low 207.06%
ATR (14) 0.17
Dividend Ex-Date -
Current Ratio 0.88
EPS Y/Y TTM 84.56%
Oper. Margin 6.47%
RSI (14) 51.72
Volatility 5.48% 6.41%
Employees 33500
Debt/Eq -
Sales Y/Y TTM 6.43%
Profit Margin -5.92%
Recom 3.25
Target Price 2.64
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 65.68%
Payout -
Rel Volume 2.19
Prev Close 2.62
Sales Surprise 1.38%
EPS Surprise 39.88%
Sales Q/Q 5.20%
Earnings May 09 BMO
Avg Volume 93.78K
Price 2.61
SMA20 0.44%
SMA50 5.95%
SMA200 24.22%
Trades
Volume 205,112
Change -0.38%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-23 Downgrade
JP Morgan
Neutral → Underweight
Nov-30-23 Initiated
UBS
Sell
$1.50
May-12-23 Downgrade
Raymond James
Strong Buy → Mkt Perform
Jan-27-23 Downgrade
Credit Suisse
Neutral → Underperform
$2 → $1
Nov-21-22 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$7 → $3
Nov-17-22 Downgrade
Credit Suisse
Outperform → Neutral
$5.50 → $2
Jul-22-22 Downgrade
Jefferies
Buy → Hold
$2.50
Jul-05-22 Downgrade
Truist
Buy → Hold
Jun-21-22 Downgrade
Stephens
Overweight → Equal-Weight
$5.50 → $3.50
Jun-21-22 Downgrade
BofA Securities
Neutral → Underperform
$3 → $2
Mar-29-22 Downgrade
BofA Securities
Buy → Neutral
$10 → $5.50
May-24-21 Initiated
Truist
Buy
$15
May-24-21 Initiated
RBC Capital Mkts
Outperform
$16
May-24-21 Initiated
Raymond James
Strong Buy
$15
May-24-21 Initiated
JP Morgan
Neutral
$14
May-24-21 Initiated
Jefferies
Buy
$15
May-24-21 Initiated
Deutsche Bank
Buy
$13.50
May-24-21 Initiated
Credit Suisse
Outperform
$16
May-24-21 Initiated
BMO Capital Markets
Outperform
$17
May-24-21 Initiated
Barclays
Overweight
$20
Show Previous Ratings
May-20-24 07:00AM
May-13-24 11:02AM
10:42AM
May-10-24 02:52PM
May-09-24 10:54AM
09:30AM
Loading…
09:30AM
07:40AM
06:41AM
(Associated Press Finance)
06:30AM
May-08-24 09:15AM
May-03-24 06:30AM
May-01-24 06:30AM
Apr-18-24 06:30AM
Apr-03-24 06:30AM
Mar-16-24 02:58PM
12:12AM
Loading…
Mar-15-24 12:12AM
(Thomson Reuters StreetEvents)
Mar-14-24 09:30AM
07:55AM
07:51AM
07:09AM
(Associated Press Finance)
06:30AM
Feb-22-24 06:30AM
Dec-11-23 07:30AM
Nov-14-23 09:40AM
Nov-11-23 09:38AM
Nov-10-23 03:32AM
(Thomson Reuters StreetEvents) +5.26%
Nov-09-23 09:30AM
07:04AM
06:47AM
(Associated Press Finance)
06:00AM
09:33AM
Loading…
Nov-08-23 09:33AM
Oct-25-23 09:01AM
Oct-19-23 06:30AM
Aug-12-23 08:23AM
Aug-11-23 04:03AM
(Thomson Reuters StreetEvents)
Aug-10-23 09:30AM
07:50AM
06:45AM
(Associated Press Finance)
06:30AM
Aug-04-23 08:00AM
Jul-20-23 06:00AM
Jul-17-23 08:48AM
Jun-15-23 07:00AM
May-22-23 06:44AM
May-17-23 08:30AM
May-12-23 12:28AM
(Thomson Reuters StreetEvents)
May-11-23 07:25AM
06:20AM
06:00AM
May-04-23 10:00AM
Apr-24-23 06:00AM
Apr-08-23 10:28AM
Mar-18-23 02:03AM
Mar-17-23 05:49AM
(Thomson Reuters StreetEvents) -6.47%
Mar-16-23 09:35AM
08:00AM
Feb-27-23 04:05PM
Feb-05-23 08:14AM
Jan-05-23 06:29AM
Jan-04-23 07:35AM
Dec-18-22 11:53AM
Dec-15-22 11:12AM
(American City Business Journals) -6.29%
Dec-13-22 05:07PM
Dec-08-22 07:18AM
Nov-11-22 05:30AM
Nov-09-22 05:45PM
04:05PM
Oct-30-22 10:08AM
Oct-25-22 04:05PM
Oct-06-22 06:57AM
Aug-31-22 04:55PM
Aug-12-22 07:30AM
Aug-10-22 08:25PM
07:12PM
Aug-03-22 10:00AM
Jul-25-22 02:31PM
08:44AM
Jul-24-22 10:33AM
Jul-19-22 09:00AM
Jul-08-22 08:13AM
Jun-27-22 06:18AM
Jun-15-22 06:30AM
May-23-22 07:57AM
May-12-22 06:30PM
May-11-22 05:45PM
04:05PM
08:59AM
May-10-22 08:00AM
Apr-29-22 06:44AM
Apr-21-22 08:00AM
Apr-11-22 11:34AM
Mar-31-22 06:49PM
Mar-29-22 06:30PM
12:26PM
Mar-28-22 04:15PM
Mar-01-22 04:09PM
04:06PM
Feb-14-22 05:12AM
Jan-13-22 05:38PM
Dec-27-21 04:05PM
Aveanna Healthcare Holdings, Inc. engages in providing home care services to patients. It operates through the following business segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing services. The HHH segment provides home health, hospice, and program services to predominately elderly populations. The MS segment offers supplies to patients requiring enteral nutrition services or respiratory care. The company was founded on November 30, 2016 and is headquartered in Atlanta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GANZI VICTOR F Director Jun 06 '23 Buy 1.23 200 246 236,617 Jun 08 09:50 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite